Celsion Corporation (CLSN) Q2 2020 Results Conference Call August 14, 2020 11:00 AM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Michael Tardugno - Chairman, President and Chief Executive Officer Jeffrey Church - Senior Vice President and Chief Financial Officer Nicholas Borys - Chief Medical Officer Conference Call Participants Justin Kim - Oppenheimer Raj Kumar - Brookline Capital Markets Operator Good morning. My name is Cassidy and I will be your operator today. At this time, I w ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-15911 CELSION CORPORATION (Exact name of registrant as specified in its charter) Delaware 52-1256615 (State or other jurisdiction of incorporation or organiza ...

Celsion Corporation (CLSN) Q1 2020 Results Conference Call May 15, 2020 11:00 AM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Michael Tardugno - Chairman, President and Chief Executive Officer Jeffrey Church - Senior Vice President and Chief Financial Officer Dr. Nicholas Borys - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer Matthew Cross - JonesTrading Raj Kumar - Brookline Capital Markets Operator Good morning. My name is Cathy and I will be your operat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-15911 CELSION CORPORATION (Exact name of Registrant as specified in its charter) (State or other ...

Celsion Corporation (CLSN) Q4 2019 Results Earnings Conference Call March 26, 2020 11:00 AM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Michael Tardugno - Chairman, President and Chief Executive Officer Jeffrey Church - Senior Vice President, Chief Financial Officer and Corporate Secretary Nicholas Borys - Senior Vice President and Chief Medical Officer Conference Call Participants Matthew Cross - Jones Trading Jason Kolbert - Dawson James Kumaraguru Raja - Brookline Capital Markets Op ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-15911 CELSION CORPORATION (Exact Name of Registrant as Specified in Its Charter) DELAWARE 52-1256615 (State or o ...

Celsion Corporation (CLSN) Q3 2019 Earnings Conference Call November 15, 2019 11:00 AM ET Company Participants Kim Golodetz - LHA Investor Relations Michael Tardugno - Chief Executive Officer Jeffrey Church - Chief Financial Officer Nicholas Borys - Chief Medical Officer Conference Call Participants Jason Kolbert - Dawson James Matthew Cross - Jones Trading Kumaraguru Raja - Brookline Capital Markets Yichuan Yan - Oppenheimer & Company Operator Good morning. My name is Emma and I will be your operator today ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-15911 CELSION CORPORATION (Exact name of Registrant as specified in its charter) (State or ot ...

Celsion Corporation (CLSN) Q2 2019 Earnings Conference Call August 15, 2019 11:00 AM ET Company Participants Kim Golodetz - LHA Michael Tardugno - Chairman, President & CEO Jeffrey Church - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Company Jason Kolbert - Dawson James Kumar Raja - Brookline Capital Markets Operator Good morning. My name is Travis and I will be your operator today. At this time, I would like to welcome you all to Celsion Second Quarter 2019 Financial Results Conference Ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-15911 CELSION CORPORATION (Exact name of Registrant as specified in its charter) (State or other j ...